IP Verse

Melflufen Dosage Regimens For Cancer - EP3383385

PATENT ANALYSIS

Patent Details

Grant Date
Sep 6, 2023
Company
ONCOPEPTIDES AB
Oppositions

LUIGI, RUMI

SYNTHON B.V.

More patents of Oncopeptides Ab

EP3383385

Want to monitor this patent?

Feel free to send us a message here and we will get back to you